Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Stockjet who wrote (874)	3/31/1998 4:00:00 PM
From: Jerry Olson	Read Replies (1) \| Respond to of 9523

Stockjet Noise guy, just noise!!!!!!! PFE......ooohhhhhhh yes!!!!!......">}

To: Stockjet who wrote (874)	3/31/1998 4:19:00 PM
From: Barron Von Hymen	Read Replies (1) \| Respond to of 9523

From Yahoo Reuter's Biz News: Tony Dwyer, chief market strategist at Ladenberg Thalmann, said the computer selling was part of end-of-quarter window dressing, when money mangers switch to better performing stocks and dump laggards to improve their portfolios' performance. ''It was just quarterly window-dressing, which nobody can predict,'' Dwyer said. The Nasdaq was up 14 points at 1832. How many mutual fund buyers are gonna look for PFE in the top 10 holdings of a fund when buying? Lots. So probably the fund managers are going to dress up their holdings with Pfizer stock big time. I say we meet Smith Barney's 12 month target of $125 by month end. P.S. that 125 target was made prior to FDA approval. Analysts are probably twiddling the fingers up their noses deciding what new target's gonna be now that they got the approval.